WL
Wei Li
Interim CEO of QuantX Biosciences
Boston, Massachusetts
Overview
Wei Li is a Founding Board Member at PEDIATRIX with a background in venture capital and private equity, specializing in life sciences and healthcare. Noteworthy career highlights include serving as a Founding Partner at Creacion Ventures and WuXi Healthcare Ventures, as well as investing in successful companies like Frontera Therapeutics and Kymera Therapeutics.
Wei Li's extensive experience in founding and board membership roles in multiple biopharmaceutical and biotechnology companies showcases a strong track record in business development, entrepreneurship, and investments within the healthcare sector.
Work Experience
Interim CEO
2022 - Current
Founding Board Member
2021
Interim CEO
2021 - 2022
Founding Board Member
2020
Founding Board Member
2017
Founding Board Member
2015
Founding Partner
2020
Founding Partner
2015
Founding Board Member
2019
Interim CEO
2019 - 2021
Frontera Therapeutics is an AAV gene therapy company that focuses on rAAV therapies for the global market.
Raised $160,000,000.00 from HongShan, Loyal Valley Capital, Zhengxingu Capital, Creacion Ventures, OrbiMed, Boyu Capital and Starr Investment Holdings.
Board Member
2018 - 2020
Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.
Raised $287,000,000.00 from SoftBank Vision Fund, Mirae Asset Capital, Polaris Partners, General Catalyst, Leaps by Bayer, Maverick Ventures, ARCH Venture Partners, NS Investment, Samsara BioCapital and 3E Bioventures.
Board Member
2018 - 2020